Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Oligodendroglioma × Temozolomide × Clear all

Phase

Phase 2 29 Phase 1 27 Phase 3 8 Phase 1/2 4 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Oligodendroglioma 1 Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

trametinib 1 dabrafenib 1 Temozolomide 1 Restraint, Physical 1 Outcome Assessment, Health Care 1 Observational Studies as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06625047 2025-12-31

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡